Evaluation of factors that affect the response to Etanercept and Adalimumab in treatment of Joint involvement in patients with Spondyloarthropathy and Rheumathoid Arthritis reffered to rheumatology clinics in Hamedan

Hamedan University of Medical Sciences0 sites148 target enrollmentTBD

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Not specified
Sponsor: Hamedan University of Medical Sciences
Enrollment: 148
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

last year

Study Type

Interventional

Sex

All

Investigators

Sponsor

Hamedan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

•All patients with a definitive diagnosis of rheumatoid arthritis or spondyloarthropathy who are candidates for receiving anti\-TNF drugs.

Exclusion Criteria

•The existence of contraindications for the administration of anti\-TNF (history of MS, unexplained pancytopenia, heart failure class 2 and higher, presence of active infection, etc.)
•The patient's unwillingness to cooperate
•Inability to pay for medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

The study of the predictive factors for response to Tolvaptan in Liver cirrhosis patients with water retentioiver cirrhosis with refractory water retention

JPRN-UMIN000021300Hokkaido University Graduate School of Medicine30

Completed

Phase 3

Influence of psychological factors on the response to therapy with Secukinumab in psoriasis patients on the subjective and objective levelL40.0Psoriasis vulgaris

DRKS00022104niversitätsklinikum Essen (AöR)Allgemeine Poliklinik, PsoriasisKlinik für Dermatologie, Venerologie und Allergologie120

Recruiting

N/A

Research to identify factors that predict response to enzalutamide using biopsy tissues from castration-resistant prostate cancer.castration resistant prostate cancerprostate cancer, castration-resistant, enzalutamideD064129

JPRN-jRCTs051180140Akamatsu Shusuke340

Recruiting

Phase 4

Study of influential factor to responsiveness of Tolvaptan in patients with volume overload heart failure -Multicenter prospective observational studycongestive heart failure

JPRN-UMIN000007551Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences100

Active, Not Recruiting

N/A

Investigation to identify predictors of response to a treatment with montelukast

EUCTR2005-004115-29-DEResearch Institute for the prevention of allergy and airway diseases in childhood